LIST OF TABLES AND FIGURES. Figure 1: The CompBioMed Logo (‘standard’ version) 12 Figure 2: The CompBioMed Logo ('header’ version) 12 Figure 3: CompBioMed Slide Tempate 13 Figure 4: The CompBioMed Twitter Account 15 V1.0 01/12/2016 ▇▇▇▇ ▇▇▇▇▇▇ First Draft V1.1 15/12/2016 ▇▇▇▇ ▇▇▇▇▇▇ Second Draft V1.2 21/12/2016 ▇▇▇▇▇▇ Kiri Final Draft ▇▇▇▇ ▇▇▇▇▇▇ CBK Sci Con Author ▇▇▇▇▇ ▇ ▇▇▇▇▇▇▇ UCL Editor ▇▇▇▇▇▇ ▇▇ ▇▇▇▇▇▇▇▇▇ UPF Editor ▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇ BSC Editor ▇▇▇▇ ▇▇▇▇ BSC Editor ▇▇▇ Centre of Excellence WP Work Package KPI Key Performance Indicator HPC High Performance Computing SME Small and Medium Enterprise R&D Research and Development COST European Cooperation in Science and Technology MoU Memorandum of Understanding Computational methods, based on human biology, are now reaching maturity in the biomedical domain, rendering predictive models of health and disease increasingly relevant to clinical practice by providing a personalized aspect to treatment. Computer based modelling and simulation is well established in the physical sciences and engineering, where the use of high performance computing (HPC) is now routine. CompBioMed is a user-driven Centre of Excellence (▇▇▇) in Computational Biomedicine, designed to nurture and promote the uptake and exploitation of high performance computing within the biomedical modelling community. Our user communities come from academia, industry and clinical practice. The CompBioMed Centre of Excellence in Biomedical Computing is distributed in nature, relying on collaboration within the project, and also with external stakeholders. To this end, CompBioMed will develop and coordinate dissemination activities that enable us to engage external stakeholders in academia, healthcare and industry with the activities of the project. The success of CompBioMed relies on its messages, developments, activities, and results being disseminated into the biomedical community, as well as growing and interacting with its user communities. This deliverable, D3.2: Dissemination Action Plan, acts as a detailed and comprehensive report on the dissemination actions that will be carried out by the project. This deliverable is linked to CompBioMed’s Task 3.1: Production of a Dissemination Action Plan, and the release of it is also Milestone 2 in the project. This action plan is a ‘living document’ that will be updated throughout the project, as required.
Appears in 1 contract
Sources: Grant Agreement
LIST OF TABLES AND FIGURES. Figure 1: The CompBioMed Logo (‘standard’ version) 12 11 Figure 2: The CompBioMed Logo ('header’ version) 12 Figure 3: CompBioMed Slide Tempate 13 Figure 4: The CompBioMed Twitter Account 15 V1.0 01/12/2016 ▇▇▇▇ ▇▇▇▇▇▇ First Draft V1.1 15/12/2016 ▇▇▇▇ ▇▇▇▇▇▇ Second Draft V1.2 21/12/2016 ▇▇▇▇▇▇ Kiri Final Draft ▇▇▇▇ ▇▇▇▇▇▇ CBK Sci Con Author ▇▇▇▇▇ ▇ ▇▇▇▇▇▇▇ UCL Editor ▇▇▇▇▇▇ ▇▇ ▇▇▇▇▇▇▇▇▇ UPF Editor ▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇ BSC Editor ▇▇▇▇ ▇▇▇▇ BSC Editor ▇▇▇ Centre of Excellence WP Work Package KPI Key Performance Indicator HPC High Performance Computing SME Small and Medium Enterprise R&D Research and Development COST European Cooperation in Science and Technology MoU Memorandum of Understanding Computational methods, based on human biology, are now reaching maturity in the biomedical domain, rendering predictive models of health and disease increasingly relevant to clinical practice by providing a personalized aspect to treatment. Computer based modelling and simulation is well established in the physical sciences and engineering, where the use of high performance computing (HPC) is now routine. CompBioMed is a user-driven Centre of Excellence (▇▇▇) in Computational Biomedicine, designed to nurture and promote the uptake and exploitation of high performance computing within the biomedical modelling community. Our user communities come from academia, industry and clinical practice. The CompBioMed Centre of Excellence in Biomedical Computing is distributed in nature, relying on collaboration within the project, and also with external stakeholders. To this end, CompBioMed will develop and coordinate dissemination activities that enable us to engage external stakeholders in academia, healthcare and industry with the activities of the project. The success of CompBioMed relies on its messages, developments, activities, and results being disseminated into the biomedical community, as well as growing and interacting with its user communities. This deliverable, D3.2: Dissemination Action Plan, acts as a detailed and comprehensive report on the dissemination actions that will be carried out by the project. This deliverable is linked to CompBioMed’s Task 3.1: Production of a Dissemination Action Plan, and the release of it is also Milestone 2 in the project. This action plan is a ‘living document’ that will be updated throughout the project, as required.
Appears in 1 contract
Sources: Grant Agreement